Works matching IS 11727047 AND DT 2010 AND VI 24 AND IP 1

Results: 10

Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.
Published in:
2010
By:
- Pariente A;
- Sanctussy DJ;
- Miremont-Salamé G;
- Moore N;
- Haramburu F;
- Fourrier-Réglat A;
- L'Association Française des Centres Régionaux de Pharmacovigilance (CRPV);
- Pariente, Antoine;
- Sanctussy, Dina Joseph-Reinette;
- Miremont-Salamé, Ghada;
- Moore, Nicholas;
- Haramburu, Françoise;
- Fourrier-Réglat, Annie
Publication type:
journal article
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Published in:
2010
By:
- Watanabe N;
- Omori IM;
- Nakagawa A;
- Cipriani A;
- Barbui C;
- McGuire H;
- Churchill R;
- Furukawa TA;
- MANGA (Meta-Analysis of New Generation Antidepressants) Study Group;
- Watanabe, Norio;
- Omori, Ichiro M;
- Nakagawa, Atsuo;
- Cipriani, Andrea;
- Barbui, Corrado;
- McGuire, Hugh;
- Churchill, Rachel;
- Furukawa, Toshi A
Publication type:
journal article
Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment.
Published in:
2010
By:
- Castrén E;
- Rantamäki T;
- Castrén, Eero;
- Rantamäki, Tomi
Publication type:
journal article
Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents.
Published in:
CNS Drugs, 2010, v. 24, n. 1, p. 85, doi. 10.2165/11203670-000000000-00000
By:
- Garnock-Jones, Karly P.;
- Keating, Gillian M.
Publication type:
Article
Safety Reporting and Adverse-Event Profile of Mirtazapine Described in Randomized Controlled Trials in Comparison with Other Classes of Antidepressants in the Acute-Phase Treatment of Adults with Depression.
Published in:
CNS Drugs, 2010, v. 24, n. 1, p. 35, doi. 10.2165/11319480-000000000-00000
By:
- Watanabe, Norio;
- Omori, Ichiro M.;
- Nakagawa, Atsuo;
- Cipriani, Andrea;
- Barbui, Corrado;
- McGuire, Hugh;
- Churchill, Rachel;
- Furukawa, Toshi A.
Publication type:
Article
Role of Brain-Derived Neurotrophic Factor in the Aetiology of Depression.
Published in:
CNS Drugs, 2010, v. 24, n. 1, p. 1, doi. 10.2165/11530010-000000000-00000
By:
- Castrén, Eero;
- Rantamäki, Tomi
Publication type:
Article
Role of Antiepileptic Drugs as Preventive Agents for Migraine.
Published in:
CNS Drugs, 2010, v. 24, n. 1, p. 21, doi. 10.2165/11310970-000000000-00000
By:
- Vikelis, Michail;
- Rapoport, Alan M.
Publication type:
Article
Factors Associated with Serious Adverse Reactions to Cholinesterase Inhibitors.
Published in:
CNS Drugs, 2010, v. 24, n. 1, p. 55, doi. 10.2165/11530300-000000000-00000
By:
- Pariente, Antoine;
- Joseph-Reinette Sanctussy, Dina;
- Miremont-Salamé, Ghada;
- Moore, Nicholas;
- Haramburu, Françoise;
- Fourrier-Réglat, Annie
Publication type:
Article
Blonanserin: A Review of its Use in the Management of Schizophrenia.
Published in:
CNS Drugs, 2010, v. 24, n. 1, p. 65, doi. 10.2165/11202620-000000000-00000
By:
- Deeks, Emma D.;
- Keating, Gillian M.
Publication type:
Article
Progress in Defining Optimal Treatment Outcome in Schizophrenia.
Published in:
CNS Drugs, 2010, v. 24, n. 1, p. 9, doi. 10.2165/11530250-000000000-00000
By:
- Remington, Gary;
- Foussias, George;
- Agid, Ofer
Publication type:
Article